written on 07.05.2014

Merck CEO says $14B consumer sale is enough dealmaking for now


Merck may have contributed to pharma's recent M&A wave Tuesday with the announced $14.2 billion sale of its consumer health unit to Bayer. But hold it right there, Merck CEO Kenneth Frazier says: That's enough excitement for the New Jersey-based company for now, as far as he's concerned.